Your browser doesn't support javascript.
loading
Erratum: Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965].
Deng, Linglong; Petrek, Hannah; Tu, Mei-Juan; Batra, Neelu; Yu, Ai-Xi; Yu, Ai-Ming.
Afiliação
  • Deng L; Department of Orthopaedic Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan 430072, China.
  • Petrek H; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
  • Tu MJ; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
  • Batra N; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
  • Yu AX; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
  • Yu AM; Department of Orthopaedic Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan 430072, China.
Acta Pharm Sin B ; 13(8): 3577-3578, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37655312
ABSTRACT
[This corrects the article DOI 10.1016/j.apsb.2021.07.027.].
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article